Pioneer in living medicines

Company overview

Redbiotec is a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Founded in 2006 as a spin-off of the Swiss Federal Institute of Technology in Zurich (ETH Zurich), the company has won several awards, including the renowned W.A. De Vigier Award.

Redbiotec is backed by experienced institutional and private investors. Select key investors include Zürcher Kantonalbank (ZKB Group) – Switzerland’s largest cantonal bank with S&P AAA credit rating since 1994, and Redalpine Capital, a European seed and early-stage venture investor.

Our values

Prime (Leadership)

Redbiotec has the unfaltering commitment to develop the best engineered microorganisms and proteins on the market.

Respect and challenge

Equally, we respect and we challenge our competitors, suppliers, partners, shareholders and employees.

Teamwork and criticism

Our people build Redbiotec. We reveal everyone’s potential strongly supporting our colleagues while being critical individuals.